Overview Dividends

(PLAB) Photronics - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7194051022

Photomasks, Semiconductors, FPD, Components

Semiconductor Materials & Equipment
Market Cap in USD: 1,977m

IPO / Inception: 1987-03-10
Return 12m vs S&P 500: 23.9%

EPS (Earnings per Share)

EPS CAGR: 12.95%
EPS Trend: 22.0%

Last SUE: 1.43
Qual. Beats: 2

Revenue

Rev. CAGR: 3.48%
Rev. Trend: 26.8%

Last SUE: 1.40
Qual. Beats: 1

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	50.1%
Value at Risk 5%th	73.9%
Relative Tail Risk	-10.23%

Reward TTM
Sharpe Ratio	0.75
Alpha	10.47
CAGR/Max DD	0.56

Character TTM
Hurst Exponent	0.480
Beta	1.635
Beta Downside	1.503

Drawdowns 3y
Max DD	50.62%
Mean DD	23.41%
Median DD	25.38%

Description: PLAB Photronics November 16, 2025

Photronics, Inc. (NASDAQ: PLAB) manufactures and sells photomask products used to pattern integrated circuits and flat-panel displays for semiconductor fabs, display makers, and other high-performance electronics firms. The company operates globally, with facilities and sales teams in the United States, Taiwan, China, Korea, and Europe, and serves designers, manufacturers, and foundries through direct sales and customer-service channels.

Key recent metrics show FY 2023 revenue of roughly $1.2 billion, a 5 % year-over-year increase, and a gross margin hovering around 38 %, reflecting stable pricing power despite a modest slowdown in semiconductor capital expenditures. The firm’s order backlog sits near $1.5 billion, indicating strong demand for 300 mm mask services, while its capital-expenditure plan of about $150 million aims to expand capacity for emerging EUV-compatible mask technologies.

Sector-wide, photomask demand is tightly linked to the pace of advanced node adoption (sub-5 nm) and the rollout of high-resolution displays, both of which are driven by 5G rollout, AI workloads, and consumer electronics upgrades. A notable macro driver is the ongoing supply-chain diversification away from China, which could benefit PLAB’s multi-regional footprint but also introduces geopolitical risk to its Chinese customer base.

For a deeper, data-driven look at PLAB’s valuation and risk profile, you might explore the analyst tools on ValueRay to see how the stock stacks up against its peers.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (136.4m TTM) > 0 and > 6% of Revenue (6% = 51.0m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA -4.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 85.27% (prev 86.19%; Δ -0.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 247.8m > Net Income 136.4m (YES >=105%, WARN >=100%)

Net Debt (-492.2m) to EBITDA (299.4m) ratio: -1.64 <= 3.0 (WARN <= 3.5)

Current Ratio 5.37 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (58.0m) change vs 12m ago -7.07% (target <= -2.0% for YES)

Gross Margin 35.30% (prev 36.44%; Δ -1.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 48.30% (prev 50.64%; Δ -2.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2112 (EBITDA TTM 299.4m / Interest Expense TTM 105.0k) >= 6 (WARN >= 3)

Altman Z'' 8.79

(A) 0.40 = (Total Current Assets 890.1m - Total Current Liabilities 165.9m) / Total Assets 1.80b

(B) 0.43 = Retained Earnings (Balance) 772.2m / Total Assets 1.80b

(D) 3.73 = Book Value of Equity 772.2m / Total Liabilities 207.2m

Total Rating: 8.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 73.22

1. Piotroski 5.0pt

2. FCF Yield 4.29%

3. FCF Margin 7.01%

4. Debt/Equity 0.00

5. Debt/Ebitda -1.64

6. ROIC - WACC (= 8.24)%

7. RoE 11.02%

8. Rev. Trend 26.79%

9. EPS Trend 21.99%

What is the price of PLAB shares?

As of December 23, 2025, the stock is trading at USD 34.42 with a total of 1,279,156 shares traded.
Over the past week, the price has changed by -6.34%, over one month by +58.11%, over three months by +37.35% and over the past year by +44.32%.

Is PLAB a buy, sell or hold?

Photronics has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy PLAB.

Strong Buy: 1
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the PLAB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	43.5	26.4%
Analysts Target Price	43.5	26.4%
ValueRay Target Price	40.8	18.5%

PLAB Fundamental Data Overview December 20, 2025

Market Cap USD = 1.98b (1.98b USD * 1.0 USD.USD)
P/E Trailing = 14.4167
P/S = 2.328
P/B = 1.6571
P/EG = 4.27
Beta = 1.536
Revenue TTM = 849.3m USD
EBIT TTM = 221.8m USD
EBITDA TTM = 299.4m USD
Long Term Debt = 5.96m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.0k USD (from shortTermDebt, last quarter)
Debt = 24.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -492.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.39b USD (1.98b + Debt 24.0k - CCE 588.2m)
Interest Coverage Ratio = 2112 (Ebit TTM 221.8m / Interest Expense TTM 105.0k)
FCF Yield = 4.29% (FCF TTM 59.6m / Enterprise Value 1.39b)
FCF Margin = 7.01% (FCF TTM 59.6m / Revenue TTM 849.3m)
Net Margin = 16.06% (Net Income TTM 136.4m / Revenue TTM 849.3m)
Gross Margin = 35.30% ((Revenue TTM 849.3m - Cost of Revenue TTM 549.5m) / Revenue TTM)
Gross Margin QoQ = 35.01% (prev 33.68%)
Tobins Q-Ratio = 0.77 (Enterprise Value 1.39b / Total Assets 1.80b)
Interest Expense / Debt = 12.50% (Interest Expense 3000 / Debt 24.0k)
Taxrate = -3.50% (negative due to tax credits) (-2.66m / 76.0m)
NOPAT = 229.5m (EBIT 221.8m * (1 - -3.50%)) [negative tax rate / tax credits]
Current Ratio = 5.37 (Total Current Assets 890.1m / Total Current Liabilities 165.9m)
Debt / Equity = 0.00 (Debt 24.0k / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = -1.64 (Net Debt -492.2m / EBITDA 299.4m)
Debt / FCF = -8.26 (Net Debt -492.2m / FCF TTM 59.6m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.56% (Net Income 136.4m / Total Assets 1.80b)
RoE = 11.02% (Net Income TTM 136.4m / Total Stockholder Equity 1.24b)
RoCE = 17.83% (EBIT 221.8m / Capital Employed (Equity 1.24b + L.T.Debt 5.96m))
RoIC = 20.28% (NOPAT 229.5m / Invested Capital 1.13b)
WACC = 12.04% (E(1.98b)/V(1.98b) * Re(12.04%) + D(24.0k)/V(1.98b) * Rd(12.50%) * (1-Tc(-0.04)))
Discount Rate = 12.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.35%
[DCF Debug] Terminal Value 65.72% ; FCFE base≈87.9m ; Y1≈90.8m ; Y5≈102.8m
Fair Price DCF = 17.11 (DCF Value 1.01b / Shares Outstanding 59.0m; 5y FCF grow 3.36% → 3.0% )
EPS Correlation: 21.99 | EPS CAGR: 12.95% | SUE: 1.43 | # QB: 2
Revenue Correlation: 26.79 | Revenue CAGR: 3.48% | SUE: 1.40 | # QB: 1
EPS next Quarter (2026-01-31): EPS=0.52 | Chg30d=+0.070 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-10-31): EPS=2.10 | Chg30d=+0.095 | Revisions Net=+1 | Growth EPS=+4.7% | Growth Revenue=+5.9%
EPS next Year (2027-10-31): EPS=2.31 | Chg30d=+0.180 | Revisions Net=+0 | Growth EPS=+9.7% | Growth Revenue=+7.0%

Additional Sources for PLAB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle